Busca avançada
Ano de início
Entree


Beneficial Effects of Two Hydrogen Sulfide (H2S)-Releasing Derivatives of Dexamethasone with Antioxidant Activity on Atopic Dermatitis in Mice

Texto completo
Autor(es):
Mostrar menos -
Coavoy-Sanchez, Silvia Abigail ; Cerqueira, Anderson Romerio Azevedo ; Teixeira, Simone Aparecida ; Santagada, Vincenzo ; Andreozzi, Giorgia ; Corvino, Angela ; Scognamiglio, Antonia ; Sparaco, Rosa ; Caliendo, Giuseppe ; Severino, Beatrice ; Costa, Soraia Katia Pereira ; Spolidorio, Luis Carlos ; Muscara, Marcelo Nicolas
Número total de Autores: 13
Tipo de documento: Artigo Científico
Fonte: PHARMACEUTICS; v. 15, n. 7, p. 19-pg., 2023-07-01.
Resumo

Hydrogen sulfide (H2S) is particularly produced in the skin, where it participates in the regulation of inflammation, pruritus, cytoprotection, scarring, and angiogenesis. In this study, we compared the effects of dexamethasone (Dex) with two H2S-releasing Dex derivatives in a murine model of atopic dermatitis (AD) induced by topical application of 2,4-dinitrochlorobenzene (DNCB). After sensitization with DNCB, the animals were topically treated for five consecutive days with either the H2S-releasing compounds 4-hydroxy-thiobenzamide (TBZ) and 5-(p-hydroxyphenyl)-1,2-dithione-3-thione (ADT-OH), Dex, or the derivatives Dex-TBZ or Dex-ADT. Topical treatment with equimolar doses of either Dex, Dex-TBZ, or Dex-ADT resulted in similar reductions in dermatitis score, scratching behavior, edema, eosinophilia, splenomegaly, and histological changes. In contrast with Dex, the H2S-releasing derivatives prevented IL-4 elevation and oxidative modification of skin proteins. On an equimolar dose basis, Dex-TBZ, but not Dex-ADT, promoted the elevation of endogenous H2S production and GPx activity. Neither Dex-TBZ nor Dex-ADT decreased GR activity or caused hyperglycemia, as observed with Dex treatment. We conclude that the presence of H2S-releasing moieties in the Dex structure does not interfere with the anti-inflammatory effects of this corticosteroid and adds beneficial therapeutical actions to the parent compound. (AU)

Processo FAPESP: 13/04151-3 - Avaliação farmacológica dos doadores de H2S (de liberação lenta e rápida) no comportamento de prurido e inflamação relacionada em pele de camundongos
Beneficiário:Soraia Katia Pereira Costa
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 14/24518-1 - Papel do sulfeto de hidrogênio (H2S) nas respostas inflamatória e nociceptiva induzidas por carragenina na articulação temporomandibular de ratos
Beneficiário:Marcelo Nicolas Muscara
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 17/16409-6 - Efeito de compostos doadores de sulfeto de hidrogênio (H2S) na dermatite atópica experimental induzida em camundongos.
Beneficiário:Silvia Abigail Coavoy Sanchez
Modalidade de apoio: Bolsas no Brasil - Doutorado
Processo FAPESP: 19/14051-2 - Estudo sobre a participação e efeitos do sulfeto de hidrogênio (H2S) na resposta vasomotora in vitro da artéria mesentérica de camundongos
Beneficiário:Marcelo Nicolas Muscara
Modalidade de apoio: Auxílio à Pesquisa - Regular